Engaging patients in discussions about different phosphate binders and their unique characteristics is key to improving adherence and satisfaction. New therapies that reduce pill size or burden while ...

If approved, we look forward to offering OLC to CKD patients on dialysis with hyperphosphatemia.” Hyperphosphatemia is linked to increased mortality risk. Dialysis patients often face a high ...

Describe the disease burden associated with hyperphosphatemia in patients with CKD. Analyze recommended guidance for serum phosphorus targets in patients with CKD on dialysis. Develop ...